Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 65.48
+0.50 (0.77%)
At close: May 12, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 8.55 billion as of May 12, 2026. Its market cap has increased by 128.47% in one year.
Market Cap
8.55B
Enterprise Value
8.39B
Revenue
1.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
65.48
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 8.55B, an increase of 94.18%. That is a compound annual growth rate of 10.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 8.55B | 15.21% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.94B |
| Sino Biological,Inc. | 8.78B |
| GemPharmatech | 8.40B |
| Zhejiang Ausun Pharmaceutical | 8.38B |
| Bio-Thera Solutions | 8.30B |
| Nanjing Vazyme Biotech | 8.10B |
| Acrobiosystems | 7.69B |
| Chengdu Kanghua Biological Products | 7.55B |